A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head

MLA

Toshinori Murayama, et al. “A Pilot Study of Regenerative Therapy Using Controlled Release of Recombinant Human Fibroblast Growth Factor for Patients with Pre-Collapse Osteonecrosis of the Femoral Head.” International Orthopaedics, vol. 40, no. 8, pp. 1747–54. EBSCOhost, https://doi.org/10.1007/s00264-015-3083-1. Accessed 26 Feb. 2025.

APA

Toshinori Murayama, Shuichi Matsuda, Manabu Nankaku, Yasuhiko Tabata, Masayuki Yokode, Atsushi Yonezawa, Ryuta Asada, Yutaka Kuroda, Haruhiko Akiyama, Harue Tada, Satoshi Morita, Kumi Mukai, Michio Yamamoto, Kazutaka So, Toshiko Ito-Ihara, & Akira Shimizu. (n.d.). A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. International Orthopaedics, 40(8), 1747–1754. https://doi.org/10.1007/s00264-015-3083-1

Chicago

Toshinori Murayama, Shuichi Matsuda, Manabu Nankaku, Yasuhiko Tabata, Masayuki Yokode, Atsushi Yonezawa, Ryuta Asada, et al. 2025. “A Pilot Study of Regenerative Therapy Using Controlled Release of Recombinant Human Fibroblast Growth Factor for Patients with Pre-Collapse Osteonecrosis of the Femoral Head.” International Orthopaedics 40 (8): 1747–54. Accessed February 26. doi:10.1007/s00264-015-3083-1.